← Back to Patent Explorer
US4397956A Expired / Lapsed US ⏱️ 0.0 years remaining

Means for monitoring the status of control of ketoacidosis-prone diabetics

Assignee: Individual
•
Filing: 1981-12-10
•
Granted: 1983-08-09
•
Expires: 2001-12-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method and test system for monitoring the status of control of ketoacidosis-prone diabetics using pseudo-kinetic methods. Pseudo-kinetic clinical information is obtained by analysis of a single blood sample in which the blood glucose level is determined along with one or more additional indicator analytes present in patient blood, serum or plasma. The additional indicator analyte(s) provide a "historical" picture of recent events within the patient relating to glucose metabolism which, when analyzed in conjunction with the blood glucose level, provides, from a single sample, a holistic view of the degree of metabollic control in the diabetic patient which is otherwise obtainable at the present time only by the much less desirable process of drawing and analyzing multiple samples over a period of time. The additional indicator analyte may be ketone bodies.

Inventors

  • 👤 Edward T. Maggio

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 19:16
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/54; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/64; Y; Y10; Y10T; Y10T436/00; Y10T436/14; Y10T436/142222; Y10T436/143333; Y10T436/144444; Y10T436/20; Y10T436/200833; Y10T436/202499; Y10T436/203332

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 111 words
A method for monitoring the status of control of ketoacidosis-prone diabetics comprising measuring, on a single body fluid sample, the concentration levels of glucose and at least one additional indicator analyte, the additional indicator analyte being present in the body fluid in response to changes in the glucose metabolism of the diabetic within from about 5 minutes to about 12 hours of such change, and using the measured concentration level of the additional indicator analyte in conjunction with the measured concentration level of the glucose to calculate the instantaneous determination of the slope of the change of the glucose concentration and consequently reporting on the status of control of the diabetic.
Claim 2
Independent Claim 111 words
A method for monitoring the status of control of ketoacidosis-prone diabetics comprising measuring, on a single body fluid sample, the concentration levels of glucose and at least one additional indicator analyte, the additional indicator analyte being present in the body fluid in response to changes in the glucose metabolism of the diabetic within from about 5 minutes to about 12 hours of such change, and using the measured concentration level of the additional indicator analyte in conjunction with the measured concentration level of the glucose to calculate the instantaneous determination of the slope of the change of the glucose concentration and consequently reporting on the status of control of the diabetic.
Claim 3
Dependent Claim 26 words
A method as in claim 1 wherein an algorithm is used to calculate the instantaneous determination of the slope of the change of the glucose concentration.
Claim 4
Dependent Claim 12 words
A method as in claim 1 wherein the body fluid is blood.
Claim 5
Dependent Claim 14 words
A method as in claim 1 wherein the additional indicated analyte is ketone bodies.
Claim 6
Dependent Claim 98 words
A test system for monitoring the status of control of ketoacidosis-prone diabetics comprising, in combination, a test means for measuring, on a single body fluid sample, the concentration levels of glucose and at least one additional indicator analyte, the additional indicator analyte being present in the body fluid in response to changes in the glucose metabolism of the diabetic within from about 5 minutes to about 12 hours of such change, and analyzing means for calculating the instantaneous determination of the slope of the change of the glucose concentration and reporting the status of control of the diabetic.
Claim 7
Dependent Claim 98 words
A test system for monitoring the status of control of ketoacidosis-prone diabetics comprising, in combination, a test means for measuring, on a single body fluid sample, the concentration levels of glucose and at least one additional indicator analyte, the additional indicator analyte being present in the body fluid in response to changes in the glucose metabolism of the diabetic within from about 5 minutes to about 12 hours of such change, and analyzing means for calculating the instantaneous determination of the slope of the change of the glucose concentration and reporting the status of control of the diabetic.
Claim 8
Dependent Claim 15 words
A test system as in claim 5 wherein the additional indicator analyte is ketone bodies.
Claim 9
Dependent Claim 47 words
A test system as in claim 5 wherein the body fluid is whole blood and the test means comprises reagent pads coated with a membrane and a reflectance meter to measure the response of the reagent pads to the presence of glucose and the additional indicator analyte.
Claim 10
Dependent Claim 26 words
A test system as in claim 5 wherein the analyzing means comprises an algorithm for calculating the instantaneous determination of the slope of the glucose concentration.

References Cited (Backward Citations)

US3915644A Cited
US3954412A Cited
US4160646A Cited
US4147514A Cited
US4336330A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-08-08 1987-02-07 1987-08-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-08-08 1991-02-07 1991-08-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-08-08 1995-02-07 1995-08-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag